Global Botanical and Plant-Derived Drugs Market 2024-2028

Global Botanical And Plant-Derived Drugs Market 2024-2028


The botanical and plant-derived drugs market is forecasted to grow by USD 20.93 bn during 2023-2028, accelerating at a CAGR of 8.18% during the forecast period. The report on the botanical and plant-derived drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising government initiatives to promote the use of plant-derived drugs, limitations associated with conventional drugs, and growing demand for effective treatment of chronic disorders.

Technavio's botanical and plant-derived drugs market is segmented as below:

By Type
  • Oral
  • Injectables
  • Topicals
By Application
  • Infectious diseases
  • Central nervous system
  • Cardiovascular diseases
  • Respiratory diseases
  • Digestive diseases and others
By Geographical Landscape
  • Asia
  • Europe
  • North America
  • Rest of World (ROW)
This study identifies the transformation of the regulatory landscape in US as one of the prime reasons driving the botanical and plant-derived drugs market growth during the next few years. Also, the growing focus on the development of drugs for new medical fields and the emergence of new entrants with innovative products will lead to sizable demand in the market.

The report on the botanical and plant-derived drugs market covers the following areas:
  • Botanical and plant-derived drugs market sizing
  • Botanical and plant-derived drugs market forecast
  • Botanical and plant-derived drugs market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading botanical and plant-derived drugs market vendors that include Bausch Health Companies Inc., Bayer AG, Boehringer Ingelheim International GmbH, Devonian Health Group Inc., Dr. Willmar Schwabe GmbH and Co. KG, F. Hoffmann La Roche Ltd., Hetero Labs Ltd., Jaguar Health Inc., Jazz Pharmaceuticals Plc, Medigene AG, Merck KGaA, Novartis AG, Pfizer Inc., Pierre Fabre SA, Protalix Biotherapeutics Inc., Riaan Wellness Pvt. Ltd., Wilson Drugs and Pharmaceuticals Pvt. Ltd., Zea Biosciences Corp, Sanofi SA, Sun Pharmaceutical Industries Ltd., and Vertex Pharmaceuticals Inc. Also, the botanical and plant-derived drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.


1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global botanical and plant-derived drugs market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global botanical and plant-derived drugs market 2018 - 2022 ($ billion)
4.2 Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
4.3 Application Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Oral - Market size and forecast 2023-2028
Exhibit 34: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Oral - Year-over-year growth 2023-2028 (%)
6.4 Injectables - Market size and forecast 2023-2028
Exhibit 38: Chart on Injectables - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Injectables - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Injectables - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Injectables - Year-over-year growth 2023-2028 (%)
6.5 Topicals - Market size and forecast 2023-2028
Exhibit 42: Chart on Topicals - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Topicals - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Topicals - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Topicals - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Type
Exhibit 46: Market opportunity by Type ($ billion)
Exhibit 47: Data Table on Market opportunity by Type ($ billion)
7 Market Segmentation by Application
7.1 Market segments
Exhibit 48: Chart on Application - Market share 2023-2028 (%)
Exhibit 49: Data Table on Application - Market share 2023-2028 (%)
7.2 Comparison by Application
Exhibit 50: Chart on Comparison by Application
Exhibit 51: Data Table on Comparison by Application
7.3 Infectious diseases - Market size and forecast 2023-2028
Exhibit 52: Chart on Infectious diseases - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Infectious diseases - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Infectious diseases - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Infectious diseases - Year-over-year growth 2023-2028 (%)
7.4 Central nervous system - Market size and forecast 2023-2028
Exhibit 56: Chart on Central nervous system - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Central nervous system - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Central nervous system - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Central nervous system - Year-over-year growth 2023-2028 (%)
7.5 Cardiovascular diseases - Market size and forecast 2023-2028
Exhibit 60: Chart on Cardiovascular diseases - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Cardiovascular diseases - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Cardiovascular diseases - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Cardiovascular diseases - Year-over-year growth 2023-2028 (%)
7.6 Respiratory diseases - Market size and forecast 2023-2028
Exhibit 64: Chart on Respiratory diseases - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Data Table on Respiratory diseases - Market size and forecast 2023-2028 ($ billion)
Exhibit 66: Chart on Respiratory diseases - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Respiratory diseases - Year-over-year growth 2023-2028 (%)
7.7 Digestive diseases and others - Market size and forecast 2023-2028
Exhibit 68: Chart on Digestive diseases and others - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Data Table on Digestive diseases and others - Market size and forecast 2023-2028 ($ billion)
Exhibit 70: Chart on Digestive diseases and others - Year-over-year growth 2023-2028 (%)
Exhibit 71: Data Table on Digestive diseases and others - Year-over-year growth 2023-2028 (%)
7.8 Market opportunity by Application
Exhibit 72: Market opportunity by Application ($ billion)
Exhibit 73: Data Table on Market opportunity by Application ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 75: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 77: Chart on Geographic comparison
Exhibit 78: Data Table on Geographic comparison
9.3 Asia - Market size and forecast 2023-2028
Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 North America - Market size and forecast 2023-2028
Exhibit 87: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 103: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 111: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 112: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 113: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 114: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 115: Market opportunity By Geographical Landscape ($ billion)
Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 117: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 119: Overview on factors of disruption
11.4 Industry risks
Exhibit 120: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 121: Vendors covered
12.2 Market positioning of vendors
Exhibit 122: Matrix on vendor position and classification
12.3 Bausch Health Companies Inc.
Exhibit 123: Bausch Health Companies Inc. - Overview
Exhibit 124: Bausch Health Companies Inc. - Business segments
Exhibit 125: Bausch Health Companies Inc. - Key news
Exhibit 126: Bausch Health Companies Inc. - Key offerings
Exhibit 127: Bausch Health Companies Inc. - Segment focus
12.4 Bayer AG
Exhibit 128: Bayer AG - Overview
Exhibit 129: Bayer AG - Business segments
Exhibit 130: Bayer AG - Key news
Exhibit 131: Bayer AG - Key offerings
Exhibit 132: Bayer AG - Segment focus
12.5 Boehringer Ingelheim International GmbH
Exhibit 133: Boehringer Ingelheim International GmbH - Overview
Exhibit 134: Boehringer Ingelheim International GmbH - Business segments
Exhibit 135: Boehringer Ingelheim International GmbH - Key news
Exhibit 136: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 137: Boehringer Ingelheim International GmbH - Segment focus
12.6 Devonian Health Group Inc.
Exhibit 138: Devonian Health Group Inc. - Overview
Exhibit 139: Devonian Health Group Inc. - Product / Service
Exhibit 140: Devonian Health Group Inc. - Key offerings
12.7 Dr. Willmar Schwabe GmbH and Co. KG
Exhibit 141: Dr. Willmar Schwabe GmbH and Co. KG - Overview
Exhibit 142: Dr. Willmar Schwabe GmbH and Co. KG - Product / Service
Exhibit 143: Dr. Willmar Schwabe GmbH and Co. KG - Key offerings
12.8 F. Hoffmann La Roche Ltd.
Exhibit 144: F. Hoffmann La Roche Ltd. - Overview
Exhibit 145: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 146: F. Hoffmann La Roche Ltd. - Key news
Exhibit 147: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 148: F. Hoffmann La Roche Ltd. - Segment focus
12.9 Jaguar Health Inc.
Exhibit 149: Jaguar Health Inc. - Overview
Exhibit 150: Jaguar Health Inc. - Business segments
Exhibit 151: Jaguar Health Inc. - Key offerings
Exhibit 152: Jaguar Health Inc. - Segment focus
12.10 Jazz Pharmaceuticals Plc
Exhibit 153: Jazz Pharmaceuticals Plc - Overview
Exhibit 154: Jazz Pharmaceuticals Plc - Product / Service
Exhibit 155: Jazz Pharmaceuticals Plc - Key news
Exhibit 156: Jazz Pharmaceuticals Plc - Key offerings
12.11 Merck KGaA
Exhibit 157: Merck KGaA - Overview
Exhibit 158: Merck KGaA - Business segments
Exhibit 159: Merck KGaA - Key news
Exhibit 160: Merck KGaA - Key offerings
Exhibit 161: Merck KGaA - Segment focus
12.12 Novartis AG
Exhibit 162: Novartis AG - Overview
Exhibit 163: Novartis AG - Business segments
Exhibit 164: Novartis AG - Key offerings
Exhibit 165: Novartis AG - Segment focus
12.13 Pfizer Inc.
Exhibit 166: Pfizer Inc. - Overview
Exhibit 167: Pfizer Inc. - Product / Service
Exhibit 168: Pfizer Inc. - Key news
Exhibit 169: Pfizer Inc. - Key offerings
12.14 Pierre Fabre SA
Exhibit 170: Pierre Fabre SA - Overview
Exhibit 171: Pierre Fabre SA - Business segments
Exhibit 172: Pierre Fabre SA - Key offerings
Exhibit 173: Pierre Fabre SA - Segment focus
12.15 Protalix Biotherapeutics Inc.
Exhibit 174: Protalix Biotherapeutics Inc. - Overview
Exhibit 175: Protalix Biotherapeutics Inc. - Product / Service
Exhibit 176: Protalix Biotherapeutics Inc. - Key offerings
12.16 Sanofi SA
Exhibit 177: Sanofi SA - Overview
Exhibit 178: Sanofi SA - Business segments
Exhibit 179: Sanofi SA - Key news
Exhibit 180: Sanofi SA - Key offerings
Exhibit 181: Sanofi SA - Segment focus
12.17 Sun Pharmaceutical Industries Ltd.
Exhibit 182: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 183: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 184: Sun Pharmaceutical Industries Ltd. - Key news
Exhibit 185: Sun Pharmaceutical Industries Ltd. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 186: Inclusions checklist
Exhibit 187: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 188: Currency conversion rates for US$
13.4 Research methodology
Exhibit 189: Research methodology
Exhibit 190: Validation techniques employed for market sizing
Exhibit 191: Information sources
13.5 List of abbreviations
Exhibit 192: List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global botanical and plant-derived drugs market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Injectables - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Injectables - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Injectables - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Injectables - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Topicals - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Topicals - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Topicals - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Topicals - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Type ($ billion)
Exhibits47: Data Table on Market opportunity by Type ($ billion)
Exhibits48: Chart on Application - Market share 2023-2028 (%)
Exhibits49: Data Table on Application - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Application
Exhibits51: Data Table on Comparison by Application
Exhibits52: Chart on Infectious diseases - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Infectious diseases - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Infectious diseases - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Infectious diseases - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Central nervous system - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Central nervous system - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Central nervous system - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Central nervous system - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Cardiovascular diseases - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Cardiovascular diseases - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Cardiovascular diseases - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Cardiovascular diseases - Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Respiratory diseases - Market size and forecast 2023-2028 ($ billion)
Exhibits65: Data Table on Respiratory diseases - Market size and forecast 2023-2028 ($ billion)
Exhibits66: Chart on Respiratory diseases - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Respiratory diseases - Year-over-year growth 2023-2028 (%)
Exhibits68: Chart on Digestive diseases and others - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Data Table on Digestive diseases and others - Market size and forecast 2023-2028 ($ billion)
Exhibits70: Chart on Digestive diseases and others - Year-over-year growth 2023-2028 (%)
Exhibits71: Data Table on Digestive diseases and others - Year-over-year growth 2023-2028 (%)
Exhibits72: Market opportunity by Application ($ billion)
Exhibits73: Data Table on Market opportunity by Application ($ billion)
Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits75: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits77: Chart on Geographic comparison
Exhibits78: Data Table on Geographic comparison
Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits109: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits111: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits112: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits113: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits114: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits115: Market opportunity By Geographical Landscape ($ billion)
Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits117: Impact of drivers and challenges in 2023 and 2028
Exhibits118: Overview on Criticality of inputs and Factors of differentiation
Exhibits119: Overview on factors of disruption
Exhibits120: Impact of key risks on business
Exhibits121: Vendors covered
Exhibits122: Matrix on vendor position and classification
Exhibits123: Bausch Health Companies Inc. - Overview
Exhibits124: Bausch Health Companies Inc. - Business segments
Exhibits125: Bausch Health Companies Inc. - Key news
Exhibits126: Bausch Health Companies Inc. - Key offerings
Exhibits127: Bausch Health Companies Inc. - Segment focus
Exhibits128: Bayer AG - Overview
Exhibits129: Bayer AG - Business segments
Exhibits130: Bayer AG - Key news
Exhibits131: Bayer AG - Key offerings
Exhibits132: Bayer AG - Segment focus
Exhibits133: Boehringer Ingelheim International GmbH - Overview
Exhibits134: Boehringer Ingelheim International GmbH - Business segments
Exhibits135: Boehringer Ingelheim International GmbH - Key news
Exhibits136: Boehringer Ingelheim International GmbH - Key offerings
Exhibits137: Boehringer Ingelheim International GmbH - Segment focus
Exhibits138: Devonian Health Group Inc. - Overview
Exhibits139: Devonian Health Group Inc. - Product / Service
Exhibits140: Devonian Health Group Inc. - Key offerings
Exhibits141: Dr. Willmar Schwabe GmbH and Co. KG - Overview
Exhibits142: Dr. Willmar Schwabe GmbH and Co. KG - Product / Service
Exhibits143: Dr. Willmar Schwabe GmbH and Co. KG - Key offerings
Exhibits144: F. Hoffmann La Roche Ltd. - Overview
Exhibits145: F. Hoffmann La Roche Ltd. - Business segments
Exhibits146: F. Hoffmann La Roche Ltd. - Key news
Exhibits147: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits148: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits149: Jaguar Health Inc. - Overview
Exhibits150: Jaguar Health Inc. - Business segments
Exhibits151: Jaguar Health Inc. - Key offerings
Exhibits152: Jaguar Health Inc. - Segment focus
Exhibits153: Jazz Pharmaceuticals Plc - Overview
Exhibits154: Jazz Pharmaceuticals Plc - Product / Service
Exhibits155: Jazz Pharmaceuticals Plc - Key news
Exhibits156: Jazz Pharmaceuticals Plc - Key offerings
Exhibits157: Merck KGaA - Overview
Exhibits158: Merck KGaA - Business segments
Exhibits159: Merck KGaA - Key news
Exhibits160: Merck KGaA - Key offerings
Exhibits161: Merck KGaA - Segment focus
Exhibits162: Novartis AG - Overview
Exhibits163: Novartis AG - Business segments
Exhibits164: Novartis AG - Key offerings
Exhibits165: Novartis AG - Segment focus
Exhibits166: Pfizer Inc. - Overview
Exhibits167: Pfizer Inc. - Product / Service
Exhibits168: Pfizer Inc. - Key news
Exhibits169: Pfizer Inc. - Key offerings
Exhibits170: Pierre Fabre SA - Overview
Exhibits171: Pierre Fabre SA - Business segments
Exhibits172: Pierre Fabre SA - Key offerings
Exhibits173: Pierre Fabre SA - Segment focus
Exhibits174: Protalix Biotherapeutics Inc. - Overview
Exhibits175: Protalix Biotherapeutics Inc. - Product / Service
Exhibits176: Protalix Biotherapeutics Inc. - Key offerings
Exhibits177: Sanofi SA - Overview
Exhibits178: Sanofi SA - Business segments
Exhibits179: Sanofi SA - Key news
Exhibits180: Sanofi SA - Key offerings
Exhibits181: Sanofi SA - Segment focus
Exhibits182: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits183: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits184: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits185: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits186: Inclusions checklist
Exhibits187: Exclusions checklist
Exhibits188: Currency conversion rates for US$
Exhibits189: Research methodology
Exhibits190: Validation techniques employed for market sizing
Exhibits191: Information sources
Exhibits192: List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings